TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.

Akito Hata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.